oxazoles has been researched along with Alcoholic Fatty Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liong, EC; Nanji, AA; Tipoe, GL; Xiao, J | 1 |
| Khwaja, S; Miao, L; Nanji, AA; Rahemtulla, A; Tahan, SR; Zhao, S | 1 |
2 other study(ies) available for oxazoles and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Thromboxane inhibitors attenuate inflammatory and fibrotic changes in rat liver despite continued ethanol administrations.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Central Nervous System Depressants; Cyclooxygenase 2; Endotoxins; Ethanol; Fatty Liver, Alcoholic; Fibrosis; Lipid Peroxidation; Liver; Male; NF-kappa B; Oxazoles; Pyridines; Rats; Rats, Wistar; Receptors, Thromboxane; RNA, Messenger; Thromboxane-A Synthase; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2013 |
Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Fatty Liver, Alcoholic; Liver Diseases, Alcoholic; Male; Oxazoles; Rats; Rats, Wistar; Thromboxane A2; Thromboxane B2; Transforming Growth Factor alpha; Transforming Growth Factor beta | 1997 |